Clinical Data Shows Surefire Technology Achieved 79% Objective Response versus 37% Using a Standard Microcatheter in Treating Primary Liver Cancer
08 mars 2017 06h00 HE
|
Surefire Medical, Inc.
Study presented at SIR 2017 Annual Scientific Meeting WASHINGTON, March 08, 2017 (GLOBE NEWSWIRE) -- Surefire Medical, Inc. today announced that clinical data presented at the Society for...
Surefire Medical Launches New Flexion Guiding Catheter with Nitinol Tip for Better Shape Retention, Improved Back-up Support
06 mars 2017 06h00 HE
|
Surefire Medical, Inc.
WASHINGTON, March 06, 2017 (GLOBE NEWSWIRE) -- Surefire Medical, Inc. today announced the launch of the new Flexion Guiding Catheter at the Society for Interventional Radiology (SIR) meeting in...